{"entity":{"type":"insider","cik":"0001379459","url":"/insider/0001379459","json_url":"/insider/0001379459.json","name":"Chappell Dale","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":300,"n_filings":58,"first":"2006-12-08","last":"2023-10-20","span_basis":"filed_date"},"name_variants":[{"name":"Chappell Dale","source":"filing","n_filings":58,"first_seen":"2006-12-08","last_seen":"2023-10-20"}],"transactions":[{"id":8519021,"accession":"0001013594-23-000819","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-23-000819","line_url":"/filing/0001013594-23-000819","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":386350.0,"shares_display":"386,350","price_per_share":0.011,"price_display":"0.01","price_state":"stated","total_value":4249.85,"total_display":"4,249.85","total_whole":"4,250","shares_owned_after":8398871.0,"shares_owned_after_display":"8,398,871","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-18","filed_date":"2023-10-20","scope":"insider","n_lines":3},{"id":6953360,"accession":"0001013594-22-000446","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001013594-22-000446","line_url":"/filing/0001013594-22-000446","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":545488.0,"shares_display":"545,488","price_per_share":2.228,"price_display":"2.23","price_state":"stated","total_value":1215347.264,"total_display":"1,215,347.26","total_whole":"1,215,347","shares_owned_after":8675081.0,"shares_owned_after_display":"8,675,081","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-20","scope":"insider","n_lines":3},{"id":6953351,"accession":"0001013594-22-000446","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013594-22-000446","line_url":"/filing/0001013594-22-000446","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":323808.0,"shares_display":"323,808","price_per_share":2.186,"price_display":"2.19","price_state":"stated","total_value":707844.288,"total_display":"707,844.29","total_whole":"707,844","shares_owned_after":8293240.0,"shares_owned_after_display":"8,293,240","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-20","scope":"insider","n_lines":3},{"id":6953344,"accession":"0001013594-22-000446","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-22-000446","line_url":"/filing/0001013594-22-000446","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":173700.0,"shares_display":"173,700","price_per_share":1.962,"price_display":"1.96","price_state":"stated","total_value":340799.4,"total_display":"340,799.40","total_whole":"340,799","shares_owned_after":8066575.0,"shares_owned_after_display":"8,066,575","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-20","scope":"insider","n_lines":3},{"id":6715949,"accession":"0001013594-22-000291","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-22-000291","line_url":"/filing/0001013594-22-000291","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":7944985.0,"shares_owned_after_display":"7,944,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-15","scope":"insider","n_lines":3},{"id":5528177,"accession":"0001013594-21-000672","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013594-21-000672","line_url":"/filing/0001013594-21-000672","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57551.0,"shares_display":"57,551","price_per_share":17.1598,"price_display":"17.16","price_state":"stated","total_value":987563.6498,"total_display":"987,563.65","total_whole":"987,564","shares_owned_after":7266296.0,"shares_owned_after_display":"7,266,296","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-12","filed_date":"2021-08-13","scope":"insider","n_lines":3},{"id":5528167,"accession":"0001013594-21-000672","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-21-000672","line_url":"/filing/0001013594-21-000672","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":109647.0,"shares_display":"109,647","price_per_share":17.0743,"price_display":"17.07","price_state":"stated","total_value":1872145.7721,"total_display":"1,872,145.77","total_whole":"1,872,146","shares_owned_after":7308021.0,"shares_owned_after_display":"7,308,021","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-11","filed_date":"2021-08-13","scope":"insider","n_lines":3},{"id":5331528,"accession":"0001013594-21-000649","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013594-21-000649","line_url":"/filing/0001013594-21-000649","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29394.0,"shares_display":"29,394","price_per_share":17.0342,"price_display":"17.03","price_state":"stated","total_value":500703.2748,"total_display":"500,703.27","total_whole":"500,703","shares_owned_after":7366204.0,"shares_owned_after_display":"7,366,204","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-29","filed_date":"2021-07-30","scope":"insider","n_lines":3},{"id":5331516,"accession":"0001013594-21-000649","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-21-000649","line_url":"/filing/0001013594-21-000649","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9692.0,"shares_display":"9,692","price_per_share":17.0411,"price_display":"17.04","price_state":"stated","total_value":165162.3412,"total_display":"165,162.34","total_whole":"165,162","shares_owned_after":7387515.0,"shares_owned_after_display":"7,387,515","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-28","filed_date":"2021-07-30","scope":"insider","n_lines":3},{"id":4933231,"accession":"0001013594-21-000633","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001013594-21-000633","line_url":"/filing/0001013594-21-000633","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5584.0,"shares_display":"5,584","price_per_share":17.0406,"price_display":"17.04","price_state":"stated","total_value":95154.7104,"total_display":"95,154.71","total_whole":"95,155","shares_owned_after":7394542.0,"shares_owned_after_display":"7,394,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-23","filed_date":"2021-07-23","scope":"insider","n_lines":3},{"id":4933218,"accession":"0001013594-21-000633","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013594-21-000633","line_url":"/filing/0001013594-21-000633","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":178005.0,"shares_display":"178,005","price_per_share":17.0377,"price_display":"17.04","price_state":"stated","total_value":3032795.7885,"total_display":"3,032,795.79","total_whole":"3,032,796","shares_owned_after":7398590.0,"shares_owned_after_display":"7,398,590","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-22","filed_date":"2021-07-23","scope":"insider","n_lines":3},{"id":4933203,"accession":"0001013594-21-000633","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-21-000633","line_url":"/filing/0001013594-21-000633","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":132764.0,"shares_display":"132,764","price_per_share":17.1366,"price_display":"17.14","price_state":"stated","total_value":2275123.5624,"total_display":"2,275,123.56","total_whole":"2,275,124","shares_owned_after":7527644.0,"shares_owned_after_display":"7,527,644","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-21","filed_date":"2021-07-23","scope":"insider","n_lines":3},{"id":4208553,"accession":"0001013594-21-000604","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-21-000604","line_url":"/filing/0001013594-21-000604","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15177.0,"shares_display":"15,177","price_per_share":17.0552,"price_display":"17.06","price_state":"stated","total_value":258846.7704,"total_display":"258,846.77","total_whole":"258,847","shares_owned_after":7623898.0,"shares_owned_after_display":"7,623,898","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-14","filed_date":"2021-07-16","scope":"insider","n_lines":3},{"id":5528157,"accession":"0001013594-21-000584","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013594-21-000584","line_url":"/filing/0001013594-21-000584","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":296036.0,"shares_display":"296,036","price_per_share":17.3721,"price_display":"17.37","price_state":"stated","total_value":5142766.9956,"total_display":"5,142,767.00","total_whole":"5,142,767","shares_owned_after":7634901.0,"shares_owned_after_display":"7,634,901","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-09","filed_date":"2021-07-09","scope":"insider","n_lines":3},{"id":5528150,"accession":"0001013594-21-000584","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-21-000584","line_url":"/filing/0001013594-21-000584","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48010.0,"shares_display":"48,010","price_per_share":17.1654,"price_display":"17.17","price_state":"stated","total_value":824110.854,"total_display":"824,110.85","total_whole":"824,111","shares_owned_after":7849527.0,"shares_owned_after_display":"7,849,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-08","filed_date":"2021-07-09","scope":"insider","n_lines":3},{"id":4567984,"accession":"0001013594-21-000570","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001013594-21-000570","line_url":"/filing/0001013594-21-000570","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102848.0,"shares_display":"102,848","price_per_share":17.12,"price_display":"17.12","price_state":"stated","total_value":1760757.76,"total_display":"1,760,757.76","total_whole":"1,760,758","shares_owned_after":7884334.0,"shares_owned_after_display":"7,884,334","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-02","scope":"insider","n_lines":3},{"id":4567970,"accession":"0001013594-21-000570","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013594-21-000570","line_url":"/filing/0001013594-21-000570#line-6","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102219.0,"shares_display":"102,219","price_per_share":17.0979,"price_display":"17.10","price_state":"stated","total_value":1747730.2401,"total_display":"1,747,730.24","total_whole":"1,747,730","shares_owned_after":7958899.0,"shares_owned_after_display":"7,958,899","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-02","scope":"insider"},{"id":4567965,"accession":"0001013594-21-000570","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001013594-21-000570","line_url":"/filing/0001013594-21-000570#line-5","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_display_name":"BLACK HORSE CAPITAL LP","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28198.0,"shares_display":"28,198","price_per_share":17.0979,"price_display":"17.10","price_state":"stated","total_value":482126.5842,"total_display":"482,126.58","total_whole":"482,127","shares_owned_after":2171758.0,"shares_owned_after_display":"2,171,758","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-02","scope":"insider"}],"collapsed":true,"next_cursor":"2021-07-01|4567965","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001293310","name":"HUMANIGEN, INC","url":"/issuer/0001293310","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","n_filings":14,"first_seen":"2018-03-01","last_seen":"2023-10-20"},{"type":"issuer","type_label":"ISSUER","cik":"0000068145","name":"MORGANS FOODS INC","url":"/issuer/0000068145","role":"Director, Ten percent owner","n_filings":12,"first_seen":"2007-01-30","last_seen":"2011-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0000911002","name":"LODGENET INTERACTIVE CORP","url":"/issuer/0000911002","role":"Ten percent owner","n_filings":7,"first_seen":"2010-01-15","last_seen":"2010-07-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001418919","name":"CPEX Pharmaceuticals, Inc.","url":"/issuer/0001418919","role":"Ten percent owner","n_filings":5,"first_seen":"2008-07-15","last_seen":"2009-12-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001132340","name":"CLAXSON INTERACTIVE GROUP INC","url":"/issuer/0001132340","role":"Ten percent owner","n_filings":9,"first_seen":"2007-09-26","last_seen":"2007-11-16"},{"type":"issuer","type_label":"ISSUER","cik":"0000039547","name":"METROMEDIA INTERNATIONAL GROUP INC","url":"/issuer/0000039547","role":"Ten percent owner, Other","n_filings":10,"first_seen":"2006-12-08","last_seen":"2007-08-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001156295","name":"SERACARE LIFE SCIENCES INC","url":"/issuer/0001156295","role":"Other","n_filings":1,"first_seen":"2007-05-21","last_seen":"2007-05-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001379459","retrieved_at":"2026-08-22T08:39:37+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}